UNSPSC 51241853: Chlorhexidine gluconate/glycerin/hydroxyethyl cellulose

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE900. This VA Drug Class (DE900) classifies this compound as belonging to the group DERMATOLOGICALS, TOPICAL OTHER.

UNSPSC 51241853 Chlorhexidine gluconate/glycerin/hydroxyethyl cellulose is a Commodity code that describes antimicrobial oral rinses and dental hygiene products formulated with chlorhexidine gluconate, glycerin, and hydroxyethyl cellulose. State and local governments procure these products primarily for fire rescue, emergency medical services, and public health departments as part of broader medical supply inventories. The City of Tampa Fire Rescue Department's recent solicitation for medical aid supplies under ITB 25-P-00157 included antiseptic products as one component of a 32-item first aid and emergency medical procurement, though the code does not distinguish chlorhexidine formulations specifically from other antiseptics in that bid. Fire rescue and emergency services departments are the primary issuing bodies under this code, supplemented by county health departments and municipal public health agencies that stock oral rinses for disease control and hygiene protocols.

Activity under this code remains sparse in recent state and local procurement records. The single representative opportunity on file is the City of Tampa Fire Rescue Department's ITB 25-P-00157, posted April 24, 2026, with a response deadline of April 9, 2025 (note: the due date appears to predate the posting date in the source record, suggesting a data inconsistency). The procurement budgeted $100,000 across all 32 line items and included set-aside provisions for City-certified Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises, offering up to 5% bid discounts capped at $10,000 for SLBEs and $20,000 for U-WMBEs. No recent activity from other states or jurisdictions is documented in the current opportunity block, limiting visibility into geographic concentration or repeat-buyer patterns for chlorhexidine formulations specifically.